(Q48719424)

English

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

scientific article published in May 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

K G Nicholson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Y Aoki

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A D Osterhaus

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Trottier

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

O Carewicz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C H Mercier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Rode

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

N Kinnersley

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

355

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

9218

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1845-1850

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Economic impact of influenza. The individual's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Health impact of influenza in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of antivirals in influenza in the elderly: prophylaxis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of influenza B virus infection on human performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902288-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02288-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

release_w2qeak6fu5cndephgnceirpicq

1 reference

https://api.fatcat.wiki/v0/release/w2qeak6fu5cndephgnceirpicq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10866439%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48719424&oldid=1835735975"